HASHEM AZAD

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease NAPLES, FL NPI 1780945980

General Payments — all program years on this page

$5,861.84

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 145
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $433.21 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $433.2116

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,741.7227
2019 $611.4713
2020 $458.204
2021 $1,168.0719
2022 $606.7937
2023 $842.3829
2024 $433.2116

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080614979 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $23.15 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086631025 Novartis Pharmaceuticals Corporation $24.76 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086631045 Novartis Pharmaceuticals Corporation $13.47 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086631087 Novartis Pharmaceuticals Corporation $22.61 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096892313 Novo Nordisk Inc $20.88 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097253664 Novo Nordisk Inc $24.20 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111521333 Amgen Inc. $18.46 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111521335 Amgen Inc. $20.76 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111521337 Amgen Inc. $16.62 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111521339 Amgen Inc. $23.64 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111521341 Amgen Inc. $20.10 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118154019 Boehringer Ingelheim Pharmaceuticals, Inc. $15.32 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118154021 Boehringer Ingelheim Pharmaceuticals, Inc. $18.27 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118154023 Boehringer Ingelheim Pharmaceuticals, Inc. $22.24 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130875850 PFIZER INC. $123.99 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132318310 SCPHARMACEUTICALS INC. $24.74 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.